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Background
Primary angiitis of the central nervous system in children
(cPACNS) is an inflammatory vasculitis that solely affects
the CNS vessels in the absence of a systemic inflammatory
process. Circulating endothelial cells (CECs) are increas-
ingly described as biomarkers for tracking vascular injury
[1]. Additionally, bone marrow-derived endothelial pro-
genitor cells (EPCs) are thought to play a pivotal role in
the regeneration of damaged endothelium. We describe
the relationship of CECs and EPCs to clinical and/or radi-
ological disease progression in cPACNS.
Materials and methods
16 children, median age 7 years old (range 1.8–17); 9
males with cPACNS were studied. Two groups were iden-
tified, according to radiological and/or clinical progres-
sion, or non progression at >6 months from diagnosis.
CECs were isolated from whole blood using immu-
nomagnetic bead extraction. EPCs were detected using
flow cytometry and were defined as mononuclear cells tri-
ple positive for CD34/CD133/CD144 and CD34/CD133/
VEGFR2.
Results
Median CEC count in progressive cPACNS was signifi-
cantly raised to 480/ml (176–1152) compared to 36/ml
(0–168) in non-progressive disease (p = 0.0007), 32/ml
(0–152) in child control (p = 0.0050) and 24/ml (16–
141) in patients with non inflammatory cerebrovascular
pathology (p = 0.0016). CD34+CD133+CD144+ cells
were significantly raised in patients with progressive dis-
ease compared to child controls (p = 0.005) and patients
with non progressive disease (p = 0.03). There was a sim-
ilar but non significant trend for EPCs expressing CD34/
CD133/VEGFR2.
Conclusion
CECs can be used to track vascular injury due to cPACNS
and differentiate progressive versus non-progressive cere-
bral vasculitis. We also demonstrated an increase in EPCs
in progressive cPACNS, perhaps indicative of a compensa-
tory reparative vasculogenic response.
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